- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07939893
Brief Title: Paracervical Block for Postoperative Pain After Transcervical Procedures Under TIVA
EFFECTIVENESS OF PARACERVICAL BLOCK IN ADDITION TO STANDARD ANALGESIA FOR POSTOPERATIVE PAIN CONTROL FOLLOWING TRANSCERVICAL UTERINE PROCEDURES UNDER TIVA: A RANDOMIZED CONTROLLED TRIAL
Paracervical Block for Postoperative Pain After Transcervical Procedures Under TIVA
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
EFFECTIVENESS OF PARACERVICAL BLOCK IN ADDITION TO STANDARD ANALGESIA FOR POSTOPERATIVE PAIN CONTROL FOLLOWING TRANSCERVICAL UTERINE PROCEDURES UNDER TIVA: A RANDOMIZED CONTROLLED TRIAL
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Zeenat Usman, MS obstetrics and Gyanecology
- Numéro de téléphone: +923315333910
- E-mail: usmanbut2@gmail.com
Sauvegarde des contacts de l'étude
- Nom: Quratulain Assosciate Professor, FCPS - Obstetrics and Gynaecol
- Numéro de téléphone: +92335587882
- E-mail: qurratulain_saeed@yahoo.com
Lieux d'étude
-
-
Islamabad
-
Islamabad, Islamabad, Pakistan, 04485
- Pakistan Institute of Medical Sciences (PIMS)
-
Contact:
- Zeenat Usman, MS Obstetrics and gyanecology
- Numéro de téléphone: +923315333910
- E-mail: qurratulain_saeed@yahoo.com
-
Contact:
- Quratulain Associate Professor, FCPS - Obstetrics and Gynaecol
- Numéro de téléphone: +92335587882
- E-mail: qurratulain_saeed@yahoo.com
-
Chercheur principal:
- Zeenat Usman, MS obstetrics and gyane
-
Sous-enquêteur:
- Quratulain Saeed, FCPS - Obstetrics and Gynaecol
-
Sous-enquêteur:
- Tooba Batool
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Women aged 18 years or older.
- Women scheduled to undergo an eligible transcervical uterine procedure under total intravenous anaesthesia (TIVA).
- Women with stable haemodynamic condition before surgery.
Exclusion Criteria:
- Known allergy or hypersensitivity to lidocaine or other planned local anaesthetic.
- Significant hepatic disease affecting local anaesthetic metabolism.
- Chronic opioid use or chronic pain requiring regular analgesic therapy.
- Major intraoperative complication requiring deviation from the standardized anaesthetic or surgical protocol.
- Patients requiring emergency surgery where informed consent or standardized study procedures cannot safely be completed.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Paracervical Block Plus Standard Analgesia
Participants will receive a standardized paracervical block using lidocaine in addition to standard total intravenous anesthesia (TIVA) and perioperative analgesia for eligible transcervical uterine procedures. Postoperative pain scores and analgesic requirements will be assessed and compared with the control group. |
A standardized paracervical block will be administered after induction of total intravenous anesthesia (TIVA) and before uterine manipulation. The technique will use 2% lidocaine without adrenaline, with 1 mL injected at each of four cervical positions (2, 4, 8, and 10 o'clock), for a total volume of 4 mL (80 mg lidocaine). Aspiration will be performed before and during injection to reduce the risk of intravascular administration. The block will be given in addition to standard TIVA and perioperative analgesia for eligible transcervical uterine procedures. |
|
Aucune intervention: Standard Analgesia Alone
Participants will receive standard total intravenous anesthesia (TIVA) and perioperative analgesia for eligible transcervical uterine procedures without a paracervical block. Postoperative pain scores and analgesic requirements will be assessed and compared with the intervention group. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Postoperative Pain Score (0-10 Visual Analogue Scale [VAS] Score)
Délai: From arrival in the recovery area (when awake and able to communicate) to 4 hours post-procedure, assessed at recovery arrival, 30 minutes, 1 hour, 2 hours, and 4 hours where feasible.
|
Postoperative pain intensity will be measured using a 0-10 Visual Analogue Scale (VAS), with 0 representing no pain and 10 representing the worst imaginable pain. The VAS score will be recorded for each participant at recovery room arrival (when awake and able to communicate), 30 minutes, 1 hour, 2 hours, and 4 hours after the procedure, where feasible. The mean or median postoperative pain scores will be compared between participants receiving paracervical block plus standard analgesia and those receiving standard analgesia alone. |
From arrival in the recovery area (when awake and able to communicate) to 4 hours post-procedure, assessed at recovery arrival, 30 minutes, 1 hour, 2 hours, and 4 hours where feasible.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Proportion of Participants Requiring Rescue Analgesia (%)
Délai: From completion of the procedure until 4 hours post-procedure.
|
The proportion of participants requiring additional rescue analgesia for postoperative pain despite receiving standard perioperative analgesia will be recorded. Rescue analgesia requirement will be assessed as a binary outcome (Yes/No) using the study Case Report Form (CRF). The percentage of participants requiring rescue analgesia will be compared between the intervention and control groups.Control group is the one receiving standard analgesia that is only TIVA and case group is standard analgesia that is TIVA and paracervical block group |
From completion of the procedure until 4 hours post-procedure.
|
|
Time to First Rescue Analgesia (Minutes)
Délai: From completion of the procedure until 4 hours post-procedure
|
Time to first rescue analgesia will be measured in minutes from completion of the transcervical uterine procedure to administration of the first rescue analgesic. The time of administration will be documented using the medication administration record and structured Case Report Form (CRF), and compared between the two study groups. |
From completion of the procedure until 4 hours post-procedure
|
|
Total Postoperative Rescue Analgesic Requirement (Drug-Specific Dose)
Délai: From completion of the procedure until 4 hours post-procedure.
|
The total dose of additional rescue analgesic medication administered to each participant for postoperative pain will be recorded using the medication administration record and structured Case Report Form (CRF). The drug name, individual dose and total dose administered during the postoperative observation period will be documented and compared between the two study groups. Results will be expressed in the appropriate drug-specific dose units (e.g., milligrams). |
From completion of the procedure until 4 hours post-procedure.
|
|
Patient Satisfaction Score with Postoperative Pain Management (5-Point Likert Scale)
Délai: At the end of the postoperative recovery observation period, up to 4 hours after the procedure.
|
Participant satisfaction with postoperative pain management will be assessed using a predefined 5-point Likert scale recorded on the structured Case Report Form (CRF). The scale ranges from 1 (very dissatisfied), 2 (dissatisfied), 3 (neutral), 4 (satisfied), to 5 (very satisfied). Individual satisfaction scores will be recorded and compared between the two study groups. |
At the end of the postoperative recovery observation period, up to 4 hours after the procedure.
|
|
Time to First Mobilization (Minutes)
Délai: From completion of the procedure until first mobilization or discharge from the recovery area, whichever occurs first, within 4 hours post-procedure.
|
Time to first mobilization will be measured in minutes from completion of the transcervical uterine procedure to the participant's first mobilization. The time will be recorded using the structured Case Report Form (CRF) and compared between participants receiving paracervical block plus standard analgesia and those receiving standard analgesia alone. |
From completion of the procedure until first mobilization or discharge from the recovery area, whichever occurs first, within 4 hours post-procedure.
|
|
Incidence of Postoperative Nausea and Vomiting (Number and Percentage of Participants)
Délai: From arrival in the recovery area until 4 hours after completion of the procedure.
|
The incidence of postoperative nausea and vomiting will be assessed by recording the presence or absence of nausea and vomiting (Yes/No) using the structured Case Report Form (CRF). The requirement for rescue antiemetic medication will also be documented as Yes or No. Results will be expressed as the number and percentage of participants experiencing nausea and vomiting in each study group. |
From arrival in the recovery area until 4 hours after completion of the procedure.
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Zeenat Usman, MS obstetrics and Gyanecology, SZABMU,PIMS
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
- La douleur
- Manifestations neurologiques
- Complications postopératoires
- Processus pathologiques
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Douleur, Postopératoire
- Produits chimiques organiques
- Anilides
- Amides
- Composés aniline
- Amines
- Acétanilides
- Anesthésie et analgésie
- Anesthésie
- Lidocaïne
- Anesthésie obstétricale
Autres numéros d'identification d'étude
- F-5-2/2024(ERRC)30th-PIMS
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Individual participant data collected during this study will not be shared publicly or made available to external researchers. Data will be used by the study investigators for the purposes of the approved research. Participant confidentiality will be maintained in accordance with institutional ethical requirements.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .